About the Company
We do not have any company description for Alpha Cognition Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Alpha Cognition Inc.
Alpha Cognition Inc. (ACOG) Reports Q2 Loss, Tops Revenue Estimates
Alpha Cognition Inc. (ACOG) came out with a quarterly loss of $0.65 per share versus the Zacks Consensus Estimate of a loss ...
Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) Q2 2025
Alpha Cognition Inc. (NASDAQ: ACOG): Stonegate Capital Partners updates their coverage on Alpha Cognition Inc. (NASDAQ: ACOG) ...
Alpha Cognition Inc. Common Stock (NASDAQ:ACOG) Q2 2025 Earnings Call Transcript
August 14, 2025Alpha Cognition Inc. Common Stock misses on earnings expectations. Reported EPS is $-0.65 EPS, expectations were $-0.46. Operator: Greetings, and welcome to the Alpha Cognition Earnings ...
Alpha Cognition Inc. Reports Strong Q2 2025 Results
Alpha Cognition Inc ( ($ACOG) ) has released its Q2 earnings. Here is a breakdown of the information Alpha Cognition Inc presented to its ...
Alpha Cognition Inc. Reports Second Quarter 2025 Financial Results and Provides Operational Update
VANCOUVER, British Columbia & GRAPEVINE, Texas, August 14, 2025--Alpha Cognition Inc. (Nasdaq: ACOG) ("Alpha Cognition" or ...
Alpha Cognition, Inc. On Track to Secure Financing for Continued Growth
Alpha Cognition Inc. is a commercial development stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer’s ...
Alpha Cognition Inc. Reports Fourth Quarter and Full Year 2024 ...
Net loss for the year ended December 31, 2024, was $14.6 million, or $ (2.02) per share, compared to a net loss of $13.8 million, or $ (3.84) per share, in 2023. About Alpha Cognition Inc.
Alpha Cognition Inc. Reports First Quarter 2025 Financial ... - Nasdaq
Alpha Cognition Inc. today announced its financial results for the first quarter ended March 31, 2025. Alpha Cognition launched ZUNVEYL to long term care market on time and within budget.
Alpha Cognition Inc. (ACOG) Q4 2024 Earnings Call Transcript
Alpha Cognition Inc. (NASDAQ:ACOG) Q4 2024 Earnings Conference Call March 31, 2025 4:30 PM ETCompany ParticipantsHenry Du - Interim Chief Financial ...
Alpha Cognition Inc. (ACOG) Q1 2025 Earnings Call Transcript
Alpha Cognition Inc. (NASDAQ: ACOG) Q1 2025 Earnings Conference Call May 15, 2025 4:30 PM ET Company Participants Henry Du - Interim CFO Michael McFadden - CEO Lauren D'Angelo - COO Conference ...
Alpha Cognition Announces Second Quarter and Six Months Ended 2023 ...
Cash and cash equivalents at June 30, 2023 were $1.2 million. Shares of common stock outstanding at June 30, 2023 were 87,950,664. About Alpha Cognition Inc.
ACOG Stock Quote Price and Forecast | CNN
Alpha Cognition, Inc. is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis.
Similar Companies
Loading the latest forecasts...